Video

Q&A with Jagpreet Chhatwal, PhD, from Massachusetts General Hospital: Measuring Costs for Hepatitis C Treatment

Author(s):

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

Jagpreet Chhatwal, PhD, from Massachusetts General Hospital, discussed recent research on the topic during the 2015 Liver Meeting in San Francisco. As part of the study, the researchers looked at the costs of treating those patients currently diagnosed with hepatitis C as well as what it would cost to make the condition a rare disease in the future.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.